Pluripotent stem cell differentiation reveals distinct developmental pathways regulating lung versus thyroid lineage specification

Author:

Serra Maria12ORCID,Alysandratos Konstantinos-Dionysios12,Hawkins Finn12,McCauley Katherine B.12,Jacob Anjali12,Choi Jinyoung3,Caballero Ignacio S.1,Vedaie Marall1,Kurmann Anita A.3,Ikonomou Laertis12,Hollenberg Anthony N.3,Shannon John M.4,Kotton Darrell N.12ORCID

Affiliation:

1. Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA

2. The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA

3. Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA

4. Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA

Abstract

The in vitro directed differentiation of pluripotent stem cells (PSCs) through stimulation of developmental signaling pathways can generate mature somatic cell types for basic laboratory studies or regenerative therapies. However, there has been significant uncertainty regarding how to separately derive lung vs. thyroid epithelial lineages, since these two cell types each originate from Nkx2-1+ foregut progenitors, and the minimal pathways claimed to regulate their distinct lineage specification in vivo or in vitro have varied in prior reports. Here we employ PSCs to identify the key minimal signaling pathways (Wnt+BMP vs. BMP+FGF) that regulate distinct lung vs. thyroid lineage specification, respectively, from foregut endoderm. In contrast to most prior reports these minimal pathways appear to be evolutionarily conserved between mice and humans, and FGF signaling, while required for thyroid specification, unexpectedly appears to be dispensable for lung specification. Once specified, distinct Nkx2-1+ lung or thyroid progenitor pools can now be independently derived for functional 3D culture maturation, basic developmental studies, or future regenerative therapies.

Funder

National Institutes of Health

Cystic Fibrosis Foundation

Publisher

The Company of Biologists

Subject

Developmental Biology,Molecular Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3